T2DM is characterized by insulin resistance and lesions of pancreatic beta cells, resulting in a worsening glycaemic control and an increasing use of antidiabetic drugs including insulin (Kahn et al., 2009). This evidence concerns the gene INS and type 2 diabetes mellitus.